Aurora Spine Corporation
ASAPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -2.6% | 1.8% | -3.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 25.5% | 62.2% | 58% | 23.2% |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 3.2% | 2.7% | -0.9% | -7.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3.2% | -4.4% | -7.9% | -13.9% |
| EPS Diluted | -0.002 | -0.003 | -0.005 | -0.008 |
| % Growth | 30.8% | 42.2% | 45.1% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |